Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | Tofacitinib | 0.3 | uM | 2 | G-CSF | 17.0 | 65 | ||||
RA2708 | 2 | G-CSF | 14.0 | 49 | |||||||
0 | G-CSF | 19.0 | 51 | ||||||||
0 | G-CSF | 19.0 | 60 | ||||||||
0 | G-CSF | 23.0 | 49 | ||||||||
0 | G-CSF | 19.5 | 88 | ||||||||
0 | G-CSF | 18.0 | 61 | ||||||||
0 | G-CSF | 20.0 | 47 | ||||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 17.0 | 69 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | G-CSF | 18.0 | 64 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 18.5 | 64 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | G-CSF | 14.5 | 90 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 17.0 | 75 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | G-CSF | 17.0 | 83 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | G-CSF | 18.0 | 107 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | G-CSF | 14.5 | 60 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 15.0 | 35 | ||||
RA1869 | 3 | G-CSF | 17.0 | 63 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 16.0 | 83 | ||||
N2759 | 3 | G-CSF | 16.0 | 84 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 18.0 | 66 | ||||
RA1931 | 3 | G-CSF | 16.5 | 58 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | G-CSF | 18.0 | 80 | ||||
N2586 | 3 | G-CSF | 18.5 | 68 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | G-CSF | 17.0 | 87 |